As if it were not challenging enough during the “normal emergencies” [1] of the United States-led War on Drugs, research and advocacy for sane drug policies becomes even more complicated during a global pandemic.
COVID-19 has exposed the deep and enduring health and social inequities that mark our biopolitical moment, and the punitive ways that we govern people who use …
I have perhaps an unpopular position to declare: Although pre-exposure prophylaxis (PrEP) is an enormous biomedical breakthrough in the prevention of HIV, it also symbolizes much of what is wrong in current global health practice.
Since 2013, I have been working on HIV prevention research in Kenya, which, as pointed out in this series introduction, has the second highest …